Developing New Chemistry
Developing novel Radio-Labeling Methods
Developing Novel Radiopharmaceuticals
At CMIT, the quest to develop a radiopharmaceutical begins with a biologic question or medical condition. Researchers work to identify how to answer a scientific question, diagnose a disease, or evaluate therapeutic efficacy. These researchers develop new compounds and molecules with potential to increase the knowledge of molecular processes. After years of work, a radiopharmaceutical that impacts the healthcare of a sufferer of a particular ailment is hopefully produced.
Researchers assess the utility and efficacy of radiolabeled products and the efficiency of the radiolabeling process by a variety of methods at CMIT. Researchers test radiopharmaceuticals in vivo and ex vivo depending on the requirements of a given project. This work is performed utilizing radiopharmaceuticals developed in house and by collaborators and is available on a contract basis for interested parties.